Immunogenicity and safety of third-dose mRNA COVID-19 vaccines in healthy adults previously vaccinated with two doses of the ChAdOx1 vaccine
Wang‐Huei Sheng(National Taiwan University Hospital), Sui‐Yuan Chang(National Taiwan University of Science and Technology), Pin‐Hung Lin(National Taiwan University), Si‐Man Ieong(National Taiwan University), Ming‐Ju Hsieh(National Taiwan University Hospital), Ching‐Fu Pan(National Taiwan University), Hung‐Chih Yang(Johns Hopkins University), Tai‐Ling Chao(National Taiwan University)
Cited by 12
Related Papers
Stimulation of HIV-1-Specific Cytolytic T Lymphocytes Facilitates Elimination of Latent Viral Reservoir after Virus Reactivation
|Immunity|2012|707
Processing of the initiation methionine from proteins: properties of the Escherichia coli methionine aminopeptidase and its gene structure
|Journal of Bacteriology|1987|512
Cellular immune selection with hepatitis C virus persistence in humans
|The Journal of Experimental Medicine|2005|304
Prolonged virus shedding even after seroconversion in a patient with COVID-19
|Journal of Infection|2020|302